These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Evaluation of Immunogenicity and Protective Efficacy Elicited by Mycobacterium bovis BCG Overexpressing Ag85A Protein against Mycobacterium tuberculosis Aerosol Infection. Xu ZZ; Chen X; Hu T; Meng C; Wang XB; Rao Y; Zhang XM; Yin YL; Pan ZM; Jiao XA Front Cell Infect Microbiol; 2016; 6():3. PubMed ID: 26858942 [TBL] [Abstract][Full Text] [Related]
24. Recombinant bacille Calmette-Guerin coexpressing Ag85b, CFP10, and interleukin-12 elicits effective protection against Mycobacterium tuberculosis. Chen YY; Lin CW; Huang WF; Chang JR; Su IJ; Hsu CH; Cheng HY; Hsu SC; Dou HY J Microbiol Immunol Infect; 2017 Feb; 50(1):90-96. PubMed ID: 25732698 [TBL] [Abstract][Full Text] [Related]
25. The Profile of T Cell Responses in Bacille Calmette-Guérin-Primed Mice Boosted by a Novel Sendai Virus Vectored Anti-Tuberculosis Vaccine. Hu Z; Gu L; Li CL; Shu T; Lowrie DB; Fan XY Front Immunol; 2018; 9():1796. PubMed ID: 30123219 [TBL] [Abstract][Full Text] [Related]
26. A new tool for tuberculosis vaccine screening: Ex vivo Mycobacterial Growth Inhibition Assay indicates BCG-mediated protection in a murine model of tuberculosis. Zelmer A; Tanner R; Stylianou E; Damelang T; Morris S; Izzo A; Williams A; Sharpe S; Pepponi I; Walker B; Hokey DA; McShane H; Brennan M; Fletcher H BMC Infect Dis; 2016 Aug; 16():412. PubMed ID: 27519524 [TBL] [Abstract][Full Text] [Related]
27. Immunogenicity and protective efficacy of a fusion protein vaccine consisting of antigen Ag85B and HspX against Mycobacterium tuberculosis infection in mice. Li Q; Yu H; Zhang Y; Wang B; Jiang W; Da Z; Xian Q; Wang Y; Liu X; Zhu B Scand J Immunol; 2011 Jun; 73(6):568-76. PubMed ID: 21323695 [TBL] [Abstract][Full Text] [Related]
28. Protective Vaccine Efficacy of the Complete Form of PPE39 Protein from Mycobacterium tuberculosis Beijing/K Strain in Mice. Kim A; Hur YG; Gu S; Cho SN Clin Vaccine Immunol; 2017 Nov; 24(11):. PubMed ID: 28877927 [TBL] [Abstract][Full Text] [Related]
29. Novel vaccine candidates against Mycobacterium tuberculosis. Khoshnood S; Heidary M; Haeili M; Drancourt M; Darban-Sarokhalil D; Nasiri MJ; Lohrasbi V Int J Biol Macromol; 2018 Dec; 120(Pt A):180-188. PubMed ID: 30098365 [TBL] [Abstract][Full Text] [Related]
30. Nanoparticle conjugation and pulmonary delivery enhance the protective efficacy of Ag85B and CpG against tuberculosis. Ballester M; Nembrini C; Dhar N; de Titta A; de Piano C; Pasquier M; Simeoni E; van der Vlies AJ; McKinney JD; Hubbell JA; Swartz MA Vaccine; 2011 Sep; 29(40):6959-66. PubMed ID: 21787826 [TBL] [Abstract][Full Text] [Related]
31. IL-10 Impairs Local Immune Response in Lung Granulomas and Lymph Nodes during Early Wong EA; Evans S; Kraus CR; Engelman KD; Maiello P; Flores WJ; Cadena AM; Klein E; Thomas K; White AG; Causgrove C; Stein B; Tomko J; Mattila JT; Gideon H; Lin PL; Reimann KA; Kirschner DE; Flynn JL J Immunol; 2020 Feb; 204(3):644-659. PubMed ID: 31862711 [TBL] [Abstract][Full Text] [Related]
32. Immunogenicity and protective efficacy of a tuberculosis DNA vaccine expressing a fusion protein of Ag85B-Esat6-HspX in mice. Yuan W; Dong N; Zhang L; Liu J; Lin S; Xiang Z; Qiao H; Tong W; Qin C Vaccine; 2012 Mar; 30(14):2490-7. PubMed ID: 21704108 [TBL] [Abstract][Full Text] [Related]
33. The influence of remaining live BCG organisms in vaccinated mice on the maintenance of immunity to tuberculosis. Olsen AW; Brandt L; Agger EM; van Pinxteren LA; Andersen P Scand J Immunol; 2004 Sep; 60(3):273-7. PubMed ID: 15320884 [TBL] [Abstract][Full Text] [Related]
34. Mycobacterium indicus pranii as a booster vaccine enhances BCG induced immunity and confers higher protection in animal models of tuberculosis. Saqib M; Khatri R; Singh B; Gupta A; Kumar A; Bhaskar S Tuberculosis (Edinb); 2016 Dec; 101():164-173. PubMed ID: 27865389 [TBL] [Abstract][Full Text] [Related]
35. Multi-stage subunit vaccines against Mycobacterium tuberculosis: an alternative to the BCG vaccine or a BCG-prime boost? Khademi F; Derakhshan M; Yousefi-Avarvand A; Tafaghodi M; Soleimanpour S Expert Rev Vaccines; 2018 Jan; 17(1):31-44. PubMed ID: 29148853 [TBL] [Abstract][Full Text] [Related]
36. Genome wide approaches discover novel Mycobacterium tuberculosis antigens as correlates of infection, disease, immunity and targets for vaccination. Coppola M; Ottenhoff TH Semin Immunol; 2018 Oct; 39():88-101. PubMed ID: 30327124 [TBL] [Abstract][Full Text] [Related]
37. Initiation of acquired immunity in the lungs of mice lacking lymph nodes after infection with aerosolized Mycobacterium tuberculosis. Kashino SS; Vallerskog T; Martens G; Troudt J; Keyser A; Taylor J; Izzo A; Kornfeld H; Campos-Neto A Am J Pathol; 2010 Jan; 176(1):198-204. PubMed ID: 20008132 [TBL] [Abstract][Full Text] [Related]
38. Mycobacterium tuberculosis infects dendritic cells with high frequency and impairs their function in vivo. Wolf AJ; Linas B; Trevejo-Nuñez GJ; Kincaid E; Tamura T; Takatsu K; Ernst JD J Immunol; 2007 Aug; 179(4):2509-19. PubMed ID: 17675513 [TBL] [Abstract][Full Text] [Related]